Skip to main content

Animations

MJFF Publications

5651 - 5660 of 6467 Results
Title
Year
  • Year
  • 2016
  • 2014
  • 2015
  • 2016
  • 2017
  • 2024
  • 2022
  • 2024
  • 2020
  • 2024
  • Summary Details
    OPEN
    Title: Structural connectivity profile of scans without evidence of dopaminergic deficit (SWEDD) patients compared to normal controls and Parkinson’s disease patients
    Journal Name: SpringerPlus
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40064-016-3110-8
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Initial cognitive decline is associated with cortical thinning in early Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000483
    Citation Count: 207
  • Summary Details
    OPEN
    Title: Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000001609
    Citation Count: 117
  • Summary Details
    OPEN
    Title: Age at onset and Parkinson disease phenotype
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000002461
    Citation Count: 359
  • Summary Details
    OPEN
    Title: Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000004609
    Citation Count: 152
  • Summary Details
    OPEN
    Title: Biological Staging of the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the Research Neuronal α-synuclein Disease Integrated Staging System (NSD-ISS) (P11-3.009)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000204771
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemic
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.049755
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Real-World Experiences of Parkinson's Disease OFF Time and Role of Demographics
    Journal Name: Journal of Patient-Centered Research and Reviews
    Publisher: Aurora Health Care, Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.17294/2330-0698.2057
    Citation Count: 4
  • Summary Details
    OPEN
    Title: MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson’s disease
    Journal Name: Aging
    Publisher: Impact Journals, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.18632/aging.104200
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learning
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107054
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.